Strengthening America’s Pharma Supply Chain: How the RAPID Reserve Act Will Impact Shippers and Carriers
The pharmaceutical industry is once again in the national spotlight, as four U.S. senators reintroduced a bipartisan bill aimed at transforming how America sources, manufactures, and distributes critical medications. Known as the Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act, the legislation proposes bold steps to counteract ongoing drug shortages and reduce the U.S.’s reliance on foreign countries—particularly China—for active pharmaceutical ingredients (APIs) and finished drugs. As drug shortages continue to plague hospitals and pharmacies, this bill holds deep implications not just for manufacturers and policymakers—but also for shippers, carriers, and logistics providers involved in the delicate world of pharmaceutical transportation. Why the RAPID Reserve Act Matters Now The RAPID Reserve Act was originally introduced in 2023, spurred by growing alarm over critical drug shortages across the nation. According to data from the American So...